The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
tazopsine ID: ALA493786
PubChem CID: 11653181
Max Phase: Preclinical
Molecular Formula: C18H23NO6
Molecular Weight: 349.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: tazopsine | tazopsine|CHEMBL493786|DTXSID201045607|Q15427893|(1S,8R,9R,12S,13S)-4,11-dimethoxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,10-tetraene-3,8,12,13-tetrol
Canonical SMILES: COC1=C2[C@H]3NCC[C@]2(C[C@H](O)[C@@H]1O)c1c(ccc(OC)c1O)[C@H]3O
Standard InChI: InChI=1S/C18H23NO6/c1-24-10-4-3-8-11(16(10)23)18-5-6-19-13(14(8)21)12(18)17(25-2)15(22)9(20)7-18/h3-4,9,13-15,19-23H,5-7H2,1-2H3/t9-,13+,14+,15-,18-/m0/s1
Standard InChI Key: CQFMGBHPLGTYRE-ZERSTCQWSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-3.1348 -11.1666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1359 -11.9940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7075 -11.1630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4229 -10.7539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1371 -13.6380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1393 -14.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4268 -14.8759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7104 -14.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4226 -13.2259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7065 -13.6372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9963 -13.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9959 -12.3998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7119 -11.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4284 -12.4025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7125 -12.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2875 -13.6333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2917 -12.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8554 -14.8690 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4301 -15.7009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8493 -10.7543 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8507 -12.4060 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8495 -9.9293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0042 -14.0458 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.9974 -14.8799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0004 -15.7049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2818 -11.9867 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
1 2 2 0
9 15 1 6
5 6 1 0
11 16 1 0
6 7 1 0
16 17 1 0
15 17 1 0
7 8 1 0
6 18 1 1
8 10 2 0
7 19 1 1
9 10 1 0
1 20 1 0
3 4 2 0
2 21 1 0
4 1 1 0
20 22 1 0
9 5 1 0
11 23 1 1
2 14 1 0
8 24 1 0
24 25 1 0
13 3 1 0
12 26 1 1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.38Molecular Weight (Monoisotopic): 349.1525AlogP: 0.07#Rotatable Bonds: 2Polar Surface Area: 111.41Molecular Species: NEUTRALHBA: 7HBD: 5#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.57CX Basic pKa: 8.19CX LogP: -1.48CX LogD: -2.18Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.51Np Likeness Score: 1.91
References 1. Carraz M, Jossang A, Rasoanaivo P, Mazier D, Frappier F.. (2008) Isolation and antimalarial activity of new morphinan alkaloids on Plasmodium yoelii liver stage., 16 (11): [PMID:18456502 ] [10.1016/j.bmc.2008.04.033 ] 2. Rodrigues T, Prudêncio M, Moreira R, Mota MM, Lopes F.. (2012) Targeting the liver stage of malaria parasites: a yet unmet goal., 55 (3): [PMID:22122518 ] [10.1021/jm201095h ]